Schonfeld Strategic Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,953,712
| Closed | -$8.21M | – | 2535 |
|
|
2023
Q1 | $8.21M | Buy |
1,953,712
+206,112
| +12% | +$866K | 0.08% | 334 |
|
|
2022
Q4 | $10.5M | Buy |
1,747,600
+418,124
| +31% | +$2.51M | 0.09% | 292 |
|
|
2022
Q3 | $7.74M | Buy |
1,329,476
+481,776
| +57% | +$2.8M | 0.06% | 389 |
|
|
2022
Q2 | $5.06M | Buy |
847,700
+638,100
| +304% | +$3.81M | 0.05% | 431 |
|
|
2022
Q1 | $978K | Buy |
209,600
+38,400
| +22% | +$179K | 0.01% | 946 |
|
|
2021
Q4 | $424K | Buy |
171,200
+95,200
| +125% | +$236K | ﹤0.01% | 1278 |
|
|
2021
Q3 | $224K | Sell |
76,000
-1,000
| -1% | -$2.95K | ﹤0.01% | 1629 |
|
|
2021
Q2 | $193K | Buy |
77,000
+36,474
| +90% | +$91.4K | ﹤0.01% | 1645 |
|
|
2021
Q1 | $117K | Sell |
40,526
-4,574
| -10% | -$13.2K | ﹤0.01% | 1574 |
|
|
2020
Q4 | $145K | Buy |
+45,100
| New | +$145K | ﹤0.01% | 1360 |
|